DIAGNOS Inc.
DGNOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -43.9% | 5.5% | -29.4% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,377.6% | -1,919.5% | -1,578.4% | -1,054.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6,308.3% | -4,925.2% | -6,271.1% | -3,953.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,232.4% | -5,738% | -7,270.7% | -4,658.8% |
| EPS Diluted | -0.008 | -0.011 | -0.014 | -0.014 |
| % Growth | 29.4% | 19.3% | 6.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |